During American Diabetes Month, RTI-HS is joining with patient advocacy groups and the medical, research, and pharmaceutical industries in raising awareness for the nearly 30 million children and adults in the United States managing the disease.
Next step for measurement in diabetes care:
“We’re entering an era in which people can use technology to monitor their activities in different ways.”
Dr. James Rosenzweig
Senior Director of Clinical Consulting
from National Quality Forum interview
Our highly-trained staff has over 40 researchers with expertise in diabetes and endocrine disorders. They include James L. Rosenzweig, MD, Senior Director of Clinical Consulting, who led the creation of national disease management guidelines for diabetes, and was recently interviewed by the National Quality Forum. When asked about the next step for measurement in diabetes care, he noted, “We’re entering an era in which people can use technology to monitor their activities in different ways.” Read the full interview for Dr. Rosenzweig's throughts on this topic as well as diabetes prevalence and patient engagement.
You can browse through our over 200 publications that present research contributing to a better understanding of diabetes and endocrine disorders, treatments, and complications and comorbidities. Recent studies include:
Wolowacz S, Pearson I, Shannon P, Chubb B, Gundgaard J, Davies M, Briggs A. Development and validation of a cost-utility model for Type 1 diabetes mellitus.
Leal I, Sammon C, Masclee GMC, Scotti L, De Berardis G, Bezemer I, Gil M, Martin E, McGrogan A, Schmedt N, Seeger JD, Trifiro G, Pecchioli S, Varas-Lorenzo C, Smits MM, Sturkenboom MCJM, Romio S. Trends of use of non-insulin blood glucose lowering drugs in Europe and USA.
Hauber AB, Tunceli K, Yang JC, Gantz I, Brodovicz KG, Alexander CM, Davies MJ, Radican L. A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus.